25 avr.: Citi: Bought New Office Space In Mumbai To House All Key Business..
25 avr.: Statoil Farms Into Ghana Deepwater Licence Operated By Hess
25/04/2012 09:09:00

Amgen To Buy Mustafa Nevzat For $700 Million

Related content
02 juin - 
Wall Street rebondit avant les promesses de vente immob..
22 avr. - 
USA/Bourse - Valeurs à suivre: CenturyTel, PepsiCo, Amg..
30 oct. - 
Amgen attaqué en justice pour une affaire de pots-de-vi..

Biotechnology firm Amgen (AMGN) will buy a 95.6% stake in Mustafa Nevzat Pharmaceuticals for $700 million, in a move to expand its presence in Turkey and the surrounding region.

The all-cash transaction has been approved by both the boards, the two companies said in a joint statement Wednesday.

MN, which supplies pharmaceuticals to the hospital sector and is a major supplier of injectable medicines in Turkey, had revenue of approximately $200 million in 2011, the statement said.

Amgen's focus on Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen, is a part of its international expansion strategy. Amgen established an affiliate in Turkey in 2010 and currently markets two products, with plans to develop its pipeline of clinical candidates for Turkey and other markets around the world.

Order free Annual Report for Amgen, Inc.

Visit http://djnewswires.ar.wilink.com/?link=AMGN or call 1-888-301-0513

(END) Dow Jones Newswires

April 25, 2012 03:09 ET (07:09 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

25 avr.: Citi: Bought New Office Space In Mumbai To House All Key Business..
25 avr.: Statoil Farms Into Ghana Deepwater Licence Operated By Hess

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
Ingen indlæg


Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
UNIBAIL-RODAMCO SE : Information financière au 30 septembre 2014
Kering :Publication mensuelle du nombre d'actions composant le capital et du nombre total de droits de vote au 15 octobre 2014
Kering : Chiffre d'affaires du 3ème trimestre 2014
VRANKEN-POMMERY MONOPOLE - Poursuite de la progression de l'activité, CA au 30.09.2014 : 179,8 M€ (+ 1,1%)
Communiqué de presse LDLC.com : CA du 1er semestre 2014 : + 21%. Objectifs annuels de CA rehaussés.

Related stock quotes

Amgen Inc 147,25 0,0% Cours de bourse inchangé

Buy and sell signals

  • Tendance
  • Moneymachine

Related companies
Get access to information and recommendations of related companies with our PLUS package.

You get access to 7 valuable investment tools.

Click here to read more about the PLUS package.
Euroinvestor dans le monde entier: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.com | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Droit d'auteur Euroinvestor A/S 2014   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
vendredi 24 octobre 2014 12:15:35
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141024.3 - EUROWEB7 - 2014-10-24 12:15:35 - 2014-10-24 12:15:35 - 4 - Website: OKAY